Published in J Rheumatol on June 01, 1996
Immune mechanisms in medium and large-vessel vasculitis. Nat Rev Rheumatol (2013) 1.48
T cells in arteritis and atherosclerosis. Curr Opin Lipidol (2008) 1.10
T cell-macrophage interactions and granuloma formation in vasculitis. Front Immunol (2014) 0.80
Giant Cell Arteritis: From Pathogenesis to Therapeutic Management. Curr Treatm Opt Rheumatol (2016) 0.77
Selective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis (2004) 0.76
Simultaneous presentation of giant cell arteritis and chronic lymphocytic leukemia. J Rheumatol (1997) 0.76
Immune Checkpoint Dysfunction in Medium and Large Vessel Vasculitis. Am J Physiol Heart Circ Physiol (2017) 0.75
Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum (1994) 14.16
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum (1998) 12.36
The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum (1990) 8.92
The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum (1990) 8.67
The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum (1990) 8.36
The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum (1990) 5.09
The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum (1990) 4.43
Lymphoid neogenesis in rheumatoid synovitis. J Immunol (2001) 3.63
Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med (1975) 3.48
The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med (1992) 3.36
Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med (1982) 3.30
Visual prognosis in giant cell arteritis. Ophthalmology (1993) 3.28
Criteria for rheumatic disease. Different types and different functions. The American College of Rheumatology Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum (1994) 3.24
Perturbation of the T-cell repertoire in patients with unstable angina. Circulation (1999) 3.20
T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A (2000) 3.06
Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med (1978) 2.99
Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med (1994) 2.98
CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest (1996) 2.95
Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum (1999) 2.90
Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol (2001) 2.78
Takayasu arteritis. A study of 32 North American patients. Medicine (Baltimore) (1985) 2.78
The influence of sex on the phenotype of rheumatoid arthritis. Arthritis Rheum (1998) 2.74
T cell activation in rheumatoid synovium is B cell dependent. J Immunol (2001) 2.73
Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation (2000) 2.56
Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med (2001) 2.41
Hypersensitivity vasculitis and Henoch-Schönlein purpura: a comparison between the 2 disorders. J Rheumatol (1992) 2.38
Skip lesions in temporal arteritis. Mayo Clin Proc (1976) 2.37
Distal extremity swelling with pitting edema in polymyalgia rheumatica. Report on nineteen cases. Arthritis Rheum (1996) 2.35
Polymyalgia rheumatica with low erythrocyte sedimentation rate at diagnosis. J Rheumatol (1999) 2.34
Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci U S A (1998) 2.33
The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med (1995) 2.27
Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum (1993) 2.11
Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. Arthritis Rheum (1997) 2.11
Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest (1992) 2.09
How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial. Rheumatology (Oxford) (2004) 2.06
Musculoskeletal manifestations of bacterial endocarditis. Ann Intern Med (1977) 2.04
Relationship of glucocorticoid dosage to serum bone Gla-protein concentration in patients with rheumatologic disorders. Arthritis Rheum (1990) 2.03
Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med (1995) 2.02
The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum (1990) 2.02
Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurence in a population-based study. Arthritis Rheum (2001) 1.97
Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor. J Clin Invest (1975) 1.86
Neurologic disease in biopsy-proven giant cell (temporal) arteritis. Neurology (1988) 1.78
Single-channel and whole-cell recordings of mitogen-regulated inward currents in human cloned helper T lymphocytes. Nature (1986) 1.78
Beta structures of alternating polypeptides and their possible prebiotic significance. Nature (1975) 1.74
Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis. J Immunol (2000) 1.73
Deletion of glycoprotein gE reduces the propagation of pseudorabies virus in the nervous system of mice after intranasal inoculation. Virology (1996) 1.72
The use and misuse of classification and diagnostic criteria for complex diseases. Ann Intern Med (1998) 1.68
Down-regulation of CD28 expression by TNF-alpha. J Immunol (2001) 1.65
Cervical interspinous bursitis in active polymyalgia rheumatica. Ann Rheum Dis (2008) 1.65
Peripheral neuropathy associated with sicca complex. Neurology (1997) 1.64
Modulation of CD4 by antigenic activation. J Immunol (1987) 1.63
Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol (1993) 1.63
Amyloid peptides are toxic via a common oxidative mechanism. Proc Natl Acad Sci U S A (1995) 1.60
Polymyalgia rheumatica and giant cell arteritis. Annu Rev Med (1978) 1.59
Functional subsets of CD4 T cells in rheumatoid synovitis. Arthritis Rheum (1998) 1.56
CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. Arthritis Rheum (2001) 1.55
How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med (1994) 1.55
T cell receptor peptide vaccination in rheumatoid arthritis: a placebo-controlled trial using a combination of Vbeta3, Vbeta14, and Vbeta17 peptides. Arthritis Rheum (1998) 1.55
Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis. J Clin Invest (1996) 1.54
Aging-related deficiency of CD28 expression in CD4+ T cells is associated with the loss of gene-specific nuclear factor binding activity. J Biol Chem (1998) 1.52
Polymyalgia rheumatica. Mayo Clin Proc (1969) 1.52
Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes. J Exp Med (1994) 1.52
The role of CD8+ CD40L+ T cells in the formation of germinal centers in rheumatoid synovitis. J Immunol (1998) 1.50
Hypocomplementemia in rheumatoid arthritis. Am J Med (1973) 1.50
Persistent suppression of virus-specific cytotoxic T cell responses after transient depletion of CD4+ T cells in vivo. J Immunol (1989) 1.47
SLE nephropathy in a patient with HIV infection: case report and review of the literature. J Rheumatol (1996) 1.46
Ectopic lymphoid organogenesis: a fast track for autoimmunity. Am J Pathol (2001) 1.46
The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum (1990) 1.46
Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum (1997) 1.44
Long-term humoral unresponsiveness in vivo, induced by treatment with monoclonal antibody against L3T4. J Exp Med (1986) 1.43
Immunohistologic and cytochemical studies of temporal arteritis. Arthritis Rheum (1983) 1.43
Interferon-gamma-producing T cells in giant cell vasculitis represent a minority of tissue-infiltrating cells and are located distant from the site of pathology. Am J Pathol (1996) 1.43
The therapeutic impact of temporal artery biopsy. Lancet (1983) 1.42
Amino acids from ultraviolet irradiation of interstellar ice analogues. Nature (2002) 1.42
Primary systemic amyloidosis presenting as giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum (1994) 1.42
Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity. Arthritis Rheum (2000) 1.42
Giant cell arteritis involving the facial artery. J Rheumatol (1995) 1.41